Internal link ProQR Receives Fast Track Designation from FDA for QR-010 for Cystic Fibrosis July 19, 2016 at 11:00 AM UTC
Internal link ProQR to Release Topline Data from Proof of Concept Study of QR-010 in Cystic Fibrosis Patients at NACFC June 21, 2016 at 01:00 PM UTC
Internal link ProQR’s Drug Candidate QR-110 for Leber’s Congenital Amaurosis Type 10 Receives EMA and FDA Orphan Drug Designation June 01, 2016 at 11:00 AM UTC
Internal link ProQR Announces Presentations at the European CF Conference and the JMP Life Science Conference June 01, 2016 at 11:00 AM UTC
Internal link ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-110 for LCA10 at the 2016 ARVO Annual Meeting April 25, 2016 at 08:00 PM UTC
Internal link ProQR to Highlight a Growing Pipeline During a Research & Development Day and Present at the Barclays Global Healthcare Conference March 01, 2016 at 12:00 PM UTC
Internal link ProQR Announces Results for the Fourth Quarter and Full Year 2015 February 17, 2016 at 12:00 PM UTC
Internal link ProQR to Present at the Leerink Partners Global Healthcare Conference February 03, 2016 at 12:00 PM UTC